INVO Bioscience Inc (INVO)
0.87
-0.05
(-5.94%)
USD |
NASDAQ |
May 06, 16:00
0.87
0.00 (0.00%)
After-Hours: 18:25
INVO Bioscience Cash from Operations (TTM): -4.755M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.755M |
| September 30, 2023 | -5.044M |
| June 30, 2023 | -5.445M |
| March 31, 2023 | -5.674M |
| December 31, 2022 | -6.603M |
| September 30, 2022 | -7.110M |
| June 30, 2022 | -7.072M |
| March 31, 2022 | -6.373M |
| December 31, 2021 | -6.030M |
| September 30, 2021 | -6.339M |
| June 30, 2021 | -5.670M |
| March 31, 2021 | -5.647M |
| December 31, 2020 | -4.775M |
| September 30, 2020 | -3.726M |
| June 30, 2020 | -3.354M |
| March 31, 2020 | -2.581M |
| December 31, 2019 | 1.370M |
| September 30, 2019 | 1.855M |
| June 30, 2019 | 2.307M |
| March 31, 2019 | 2.472M |
| December 31, 2018 | -0.653M |
| September 30, 2018 | -0.3861M |
| June 30, 2018 | -0.2964M |
| March 31, 2018 | -0.1059M |
| December 31, 2017 | -0.1813M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.2603M |
| June 30, 2017 | -0.2898M |
| March 31, 2017 | -0.368M |
| December 31, 2016 | -0.3239M |
| September 30, 2016 | -0.328M |
| June 30, 2016 | -0.296M |
| March 31, 2016 | -0.2011M |
| December 31, 2015 | -0.1516M |
| September 30, 2015 | -0.0028M |
| June 30, 2015 | -0.036M |
| March 31, 2015 | -0.0738M |
| December 31, 2011 | -0.1178M |
| September 30, 2011 | -0.049M |
| June 30, 2011 | -0.1314M |
| March 31, 2011 | -0.1967M |
| December 31, 2010 | -0.316M |
| September 30, 2010 | -0.6844M |
| June 30, 2010 | -0.8684M |
| March 31, 2010 | -0.8281M |
| December 31, 2009 | -0.9267M |
| September 30, 2009 | -1.723M |
| June 30, 2009 | -1.256M |
| March 31, 2009 | -1.336M |
| December 31, 2008 | -1.067M |
| September 30, 2008 | -0.0184M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-7.110M
Minimum
Sep 2022
2.307M
Maximum
Jun 2019
-4.246M
Average
-5.445M
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
| Abbott Laboratories | 7.261B |
| Perspective Therapeutics Inc | -36.91M |
| Xtant Medical Holdings Inc | -9.515M |
| Asensus Surgical Inc | -63.63M |
| Catheter Precision Inc | -20.62M |